Subject(s)
Arachidonate 5-Lipoxygenase/biosynthesis , Gene Expression , Keratinocytes/enzymology , Blotting, Western , Cells, Cultured , Humans , Hydroxyeicosatetraenoic Acids/metabolism , Kinetics , Leukotriene B4/metabolism , Leukotrienes/metabolism , RNA, Messenger/analysis , RNA, Messenger/biosynthesis , Time FactorsABSTRACT
Eicosanoid biosynthesis in animal cells either results from agonist-stimulated phospholipase activation (endogenous pathway) or from lipoprotein receptor-mediated uptake and lysosomal lipid hydrolase-dependent release of AA (exogenous pathway) (see Fig. 1 for schematic representation). LDL stimulates eicosanoid formation through delivery of substrate AA to enzymes of oxidative AA metabolism. The classical LDL receptor is a control point of the effects of LDL AA on eicosanoid formation in different tissues: LDL AA metabolism occurs in several cell types of mesenchymal and epithelial origin and generates the formation of distinct eicosanoid patterns in each case. The LDL AA pathway does appear to couple directly to the PGH synthase reaction, whereas it does not couple directly to the 5-lipoxygenase reaction. We expect that a more complete characterization of the LDL unsaturated fatty acid pathway in different tissue will yield additional information on the biochemistry of lipoproteins, AA, and eicosanoids.
